PacBio
Menlo Park
About PacBio
PacBio designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $2.0B
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2023)
- Ticker: nasdaq:PACB
- Website: pacb.com
- Phone: 650-618-2699
Industries & Categories
Biotechnology, Chemical, Genetics, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/pacbio-105537 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.